GPCR Activation and Signaling Neuronal survival factor TAFA2 suppresses apoptosis through binding to Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference NEW April 1 - 4, 2024 | 19th Annual Drug Discovery Chemistry April 5 - 10, 2024 | AACR Annual Meeting NEW April Development at Department of Drug Design and Pharmacology Faculty of Health and Medical Sciences Octant Apprentice

Class A GPCR GPR3 Antimalarial and Plasmodium falciparum serpentine receptor 12 targeting effect of FDA approved Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways Spliceosome mutations are associated OXER1 antagonists A 19F-qNMR-Guided Mathematical Model for G Protein-Coupled Receptor Signaling Optical Approaches US$3.75 Million Payment in Multi-Target Partnership Sosei Heptares Announces Submission of New Drug Application and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April

Methods & Updates in GPCR Research ThermoBRET: A Ligand-Engagement Nanoscale Thermostability Assay Applied and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April Development at Department of Drug Design and Pharmacology Faculty of Health and Medical Sciences NEW Octant Apprentice

Advantages of targeting GPCRs allosteric sites Allosteric sites offer a more nuanced approach to modulating

Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery Application and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April

and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April

Difficult and Conserved Protein Targets GPCR Therapeutics Expands Pipeline into Fibrosis with a Combination Approach and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April

Financial Results and Exciting Developments at Aelis Farma Ion Channel Drug Developer Maxion Therapeutics Appoints and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April

Activation of PI3K/Akt pathway by G protein-coupled receptor 37 promotes resistance to cisplatin-induced apoptosis for acute migraines Addex mGlu2 NAM Cognition Program Receives €4 Million Grant Confo Therapeutics Appoints and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April

the size of conventional antibodies, makes them highly versatile and easy to manipulate for various applications1,2 All the above lightly represent the potential applications of Nbs to facilitate the development of more

and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April

November 2 - 4: The GPCR Retreat is approaching and we are thrilled to be sponsors! forces to revolutionize transmembrane proteins characterization in drug discovery Confo Therapeutics Appoints and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April

Team as the Company Advances its Multi-Product Pipeline Toward Clinical Studies Confo Therapeutics Appoints and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April

November 2 - 4: The GPCR Retreat is approaching, and we're proud sponsors! Molecular Gating Seminar NEW March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference NEW April

receptor is dynamic Ligand recognition and G protein coupling of the human itch receptor MRGPRX1 Improved approaches Molecular Insights into GPCR Function A method for structure determination of GPCRs in various states Apelin

based on RNA-seq Reviews, GPCRs, and more Tri-part NanoLuc as a new split technology with potential applications

GPCRs in Cardiology, Endocrinology, and Taste Insights on discovery, efficacy, safety and clinical applications

GPCRome-wide analysis of G-protein-coupling diversity using a computational biology approach. Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating

Reviews, GPCRs, and more Optical approaches for investigating neuromodulation and G Protein-Coupled Receptor Sosei Heptares Webinar Presentation for Q2 FY2023 Financial Results Neurocrine Biosciences Announces Appointment Grants Under Nasdaq Listing Rule 5635(c)(4) Confo Therapeutics CEO, Cedric Ververken, will join WuXi AppTec's

GPCR Symposium on Structural and Molecular Insights on GPCR Activation is quickly approaching!

GPCR Symposium on Structural and Molecular Insights on GPCR Activation is fast approaching!

As we approach the event, we have some news to share: We’ve decided to make this event a trainee day Drugs, and more Molecular Characterization of Two Wamide Neuropeptide Signaling Systems in Mollusk Aplysia

Neuroscience Orphan receptor GPR88 as a potential therapeutic target for CNS disorders - an in silico approach

CircFKBP5 Suppresses Apoptosis and Inflammation and Promotes Osteogenic Differentiation. NMR applications to GPCR recognition by peptide ligands. Application of computational methods for class A GPCR Ligand discovery.

Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

activation, then regulate trigger receptor internalization via interaction with the adaptor protein 2 (AP2 Based on an ingenious combination of multicolor single-molecule microscopy approach with molecular dynamics diffusing on the plasma membrane leads to their recruitment and accumulation in CCPs via interaction with AP2

Methods & Updates in GPCR Research Computational design of dynamic receptor-peptide signaling complexes applied Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

The application of artificial intelligence to accelerate GPCR drug discovery. Industry News InterAx Biotech to Apply its Leading AI and Cell Signalling Technology to Support Target Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.